Have your own idea? Try our Stock Screener
Chinese (SSE) Life Sciences Industry Analysis
UpdatedSep 29, 2025
DataAggregated Company Financials
Companies27
- 7D-4.1%
- 3M35.0%
- 1Y75.5%
- YTD62.6%
Over the last 7 days, the Life Sciences industry has dropped 4.1%, driven by a pullback from WuXi AppTec of 5.4%. In contrast, Shanghai Haoyuan Chemexpress has gained 7.4%. In the past year, the industry has gained 75%. As for the next few years, earnings are expected to grow by 22% per annum.
Industry Valuation and Performance
Has the Chinese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 29 Sep 2025 | CN¥604.6b | CN¥92.1b | CN¥17.4b | 72.2x | 34.7x | 6.6x |
| Wed, 27 Aug 2025 | CN¥595.8b | CN¥92.5b | CN¥17.6b | 59.9x | 33.8x | 6.4x |
| Fri, 25 Jul 2025 | CN¥535.4b | CN¥89.8b | CN¥15.4b | 56.8x | 34.9x | 6x |
| Sun, 22 Jun 2025 | CN¥413.5b | CN¥89.8b | CN¥15.4b | 45x | 26.9x | 4.6x |
| Tue, 20 May 2025 | CN¥389.3b | CN¥89.1b | CN¥15.3b | 44.1x | 25.5x | 4.4x |
| Thu, 17 Apr 2025 | CN¥361.9b | CN¥88.6b | CN¥14.0b | 36.8x | 25.8x | 4.1x |
| Sat, 15 Mar 2025 | CN¥441.1b | CN¥89.0b | CN¥11.3b | 43.4x | 38.9x | 5x |
| Mon, 10 Feb 2025 | CN¥386.2b | CN¥88.1b | CN¥11.2b | 39.8x | 34.3x | 4.4x |
| Wed, 08 Jan 2025 | CN¥347.9b | CN¥87.8b | CN¥11.2b | 34.7x | 31.1x | 4x |
| Fri, 06 Dec 2024 | CN¥370.2b | CN¥87.8b | CN¥11.2b | 40.3x | 33.1x | 4.2x |
| Sun, 03 Nov 2024 | CN¥364.8b | CN¥87.8b | CN¥11.2b | 37x | 32.6x | 4.2x |
| Tue, 01 Oct 2024 | CN¥379.0b | CN¥88.2b | CN¥12.4b | 35.3x | 30.6x | 4.3x |
| Thu, 29 Aug 2024 | CN¥268.3b | CN¥87.5b | CN¥12.8b | 23.9x | 21x | 3.1x |
| Sat, 27 Jul 2024 | CN¥278.5b | CN¥88.3b | CN¥13.4b | 25.9x | 20.8x | 3.2x |
| Mon, 24 Jun 2024 | CN¥294.0b | CN¥88.3b | CN¥13.4b | 25.9x | 22x | 3.3x |
| Wed, 22 May 2024 | CN¥326.3b | CN¥88.3b | CN¥13.3b | 29.7x | 24.5x | 3.7x |
| Fri, 19 Apr 2024 | CN¥312.2b | CN¥90.3b | CN¥15.0b | 30.5x | 20.8x | 3.5x |
| Sun, 17 Mar 2024 | CN¥364.4b | CN¥90.5b | CN¥15.5b | 33.6x | 23.5x | 4x |
| Tue, 13 Feb 2024 | CN¥348.6b | CN¥91.1b | CN¥16.1b | 29.9x | 21.7x | 3.8x |
| Thu, 11 Jan 2024 | CN¥439.4b | CN¥91.1b | CN¥16.1b | 35.3x | 27.3x | 4.8x |
| Sat, 09 Dec 2023 | CN¥493.1b | CN¥91.1b | CN¥16.1b | 36.4x | 30.7x | 5.4x |
| Mon, 06 Nov 2023 | CN¥537.9b | CN¥91.0b | CN¥16.1b | 38.2x | 33.5x | 5.9x |
| Wed, 04 Oct 2023 | CN¥520.4b | CN¥92.0b | CN¥18.3b | 35.6x | 28.4x | 5.7x |
| Fri, 01 Sep 2023 | CN¥501.6b | CN¥91.8b | CN¥18.3b | 35.1x | 27.4x | 5.5x |
| Sun, 30 Jul 2023 | CN¥471.1b | CN¥91.2b | CN¥18.3b | 34.1x | 25.7x | 5.2x |
| Tue, 27 Jun 2023 | CN¥458.4b | CN¥91.3b | CN¥18.5b | 34x | 24.8x | 5x |
| Thu, 25 May 2023 | CN¥503.9b | CN¥91.3b | CN¥18.5b | 40x | 27.3x | 5.5x |
| Sat, 22 Apr 2023 | CN¥557.5b | CN¥91.2b | CN¥19.1b | 49x | 29.2x | 6.1x |
| Mon, 20 Mar 2023 | CN¥554.2b | CN¥85.7b | CN¥20.0b | 48.7x | 27.8x | 6.5x |
| Wed, 15 Feb 2023 | CN¥660.8b | CN¥86.6b | CN¥20.8b | 55.9x | 31.7x | 7.6x |
| Fri, 13 Jan 2023 | CN¥656.0b | CN¥86.6b | CN¥20.8b | 55.3x | 31.5x | 7.6x |
| Sun, 11 Dec 2022 | CN¥596.8b | CN¥86.6b | CN¥20.8b | 50.8x | 28.7x | 6.9x |
| Tue, 08 Nov 2022 | CN¥636.3b | CN¥86.5b | CN¥20.8b | 53.2x | 30.6x | 7.4x |
| Thu, 06 Oct 2022 | CN¥536.4b | CN¥78.2b | CN¥16.9b | 44.3x | 31.7x | 6.9x |
Price to Earnings Ratio
31.7x
Current Industry PE
- Investors are optimistic on the Chinese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 34.7x which is higher than its 3-year average PE of 28.5x.
- The 3-year average PS ratio of 5.1x is lower than the industry's current PS ratio of 6.6x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 5.6% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Chinese Healthcare industry?
| CN Market | 0.035% | |
| Healthcare | -1.99% | |
| Life Sciences | -4.05% | |
| Clinical Research and Equipment | -4.05% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 688755 Jiangsu Hanbon Science and Technology | CN¥45.68 | 0.02% +CN¥880.0k | n/a | PE57.9x |